Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 52330 [2011-21420]

Download as PDF 52330 Federal Register / Vol. 76, No. 162 / Monday, August 22, 2011 / Notices program partners/collaborators identified by each Program Director (1– 2 partners per Director) as instrumental to the selection and implementation of cancer control EBPs. The survey results will help CDC enhance existing NCCCP efforts by identifying new strategies for promoting the use of evidence-based approaches to comprehensive cancer control. The surveys will also identify future studies. CDC’s authorization to conduct the study is provided by Section 301 of the Public Health Service Act (42 U.S.C. 241). OMB approval will be requested for one year. Participation in the study is voluntary. There are no costs to the respondents other than their time. technical assistance needs of NCCCPfunded awardees related to selection and implementation of EBPs, and will contribute to CDC’s efforts to build the capacities of states, Tribes, and Pacific Island Jurisdictions and territories toward more effective efforts in cancer prevention and control. Finally, the results may lead to new insights and questions that can be addressed in ESTIMATED ANNUALIZED BURDEN HOURS Form name CCC Program Directors ........... Total .......................................... ................................................................... Catina Conner, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. 2011–21400 Filed 8–19–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Member Conflict Review, Program Announcement (PA) 07–318, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: jlentini on DSK4TPTVN1PROD with NOTICES Number of responses per respondent 66 66 1 1 15/60 0.5 17 33 66 1 20/60 22 132 1 0.5 66 ........................ ........................ ........................ 138 Survey Scheduling Script ......................... Program Directors Web Survey Questionnaire. Program Directors Telephone Interview Guide and Script. Program Partners Web Survey Questionnaire. CCC Program Partners ............ Time and Date: 1 p.m.–3 p.m., November 9, 2011 (Closed). Place: National Institute for Occupational Safety and Health (NIOSH), CDC, 1095 Willowdale Road, Morgantown, West Virginia 26506, Telephone: (304) 285–6143. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Member Conflict Review, PA 07–318.’’ VerDate Mar<15>2010 18:50 Aug 19, 2011 Jkt 223001 Contact Person for More Information: Bernadine Kuchinski, PhD, Scientific Review Officer, Office of Extramural Programs, NIOSH, CDC, Robert A. Taft Laboratories, 4676 Columbia Parkway, MS C–7, Cincinnati, Ohio 45226, Telephone: (513) 533–8511. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Dated: August 12, 2011. Elizabeth Millington, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–21420 Filed 8–19–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Times and Dates: 8 a.m.–5 p.m., October 18, 2011 (Closed). 8 a.m.–5 p.m., October 19, 2011 (Closed). PO 00000 Frm 00028 Average burden per response (in hours) Number of respondents Type of Respondent Fmt 4703 Sfmt 4703 Total response burden (in hours) Place: Embassy Suites, 1900 Diagonal Road, Alexandria, Virginia 22314, Telephone: (703) 684–5900, Fax: (703) 684– 0653. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Purpose: The Safety and Occupational Health Study Section will review, discuss, and evaluate grant application(s) received in response to the Institute’s standard grants review and funding cycles pertaining to research issues in occupational safety and health, and allied areas. It is the intent of NIOSH to support broadbased research endeavors in keeping with the Institute’s program goals. This will lead to improved understanding and appreciation for the magnitude of the aggregate health burden associated with occupational injuries and illnesses, as well as to support more focused research projects, which will lead to improvements in the delivery of occupational safety and health services, and the prevention of work-related injury and illness. It is anticipated that research funded will promote these program goals. Matters To Be Discussed: The meeting will convene to address matters related to the conduct of Study Section business and for the study section to consider safety and occupational health-related grant applications. These portions of the meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, Centers for Disease Control and Prevention, pursuant to Section 10(d) Pub. L. 92–463. E:\FR\FM\22AUN1.SGM 22AUN1

Agencies

[Federal Register Volume 76, Number 162 (Monday, August 22, 2011)]
[Notices]
[Page 52330]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-21420]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Member Conflict Review, 
Program Announcement (PA) 07-318, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 1 p.m.-3 p.m., November 9, 2011 (Closed).
    Place: National Institute for Occupational Safety and Health 
(NIOSH), CDC, 1095 Willowdale Road, Morgantown, West Virginia 26506, 
Telephone: (304) 285-6143.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Member Conflict Review, PA 07-318.''
    Contact Person for More Information: Bernadine Kuchinski, PhD, 
Scientific Review Officer, Office of Extramural Programs, NIOSH, 
CDC, Robert A. Taft Laboratories, 4676 Columbia Parkway, MS C-7, 
Cincinnati, Ohio 45226, Telephone: (513) 533-8511.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention, 
and the Agency for Toxic Substances and Disease Registry.

    Dated: August 12, 2011.
Elizabeth Millington,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2011-21420 Filed 8-19-11; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.